Integra LifeSciences Holdings Corporation
$11.16
▼
-0.42%
2026-04-21 07:25:01
www.integralife.com
NMS: IART
Explore Integra LifeSciences Holdings Corporation stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$875.54 M
Current Price
$11.16
52W High / Low
$17.54 / $8.7
Stock P/E
—
Book Value
$13.4
Dividend Yield
—
ROCE
0.57%
ROE
-39.9%
Face Value
—
EPS
$-6.74
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
4,427
Beta
1.06
Debt / Equity
195.01
Current Ratio
2.54
Quick Ratio
1.46
Forward P/E
3.86
Price / Sales
0.47
Enterprise Value
$2.54 B
EV / EBITDA
8.54
EV / Revenue
1.55
Rating
None
Target Price
$15.57
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Leverage is relatively high.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Neuronetics, Inc. | $1.58 | — | $109.46 M | — | -28.31% | -1.35% | $4.85 / $0.8 | $0.32 |
| 2. | HeartSciences Inc. | $2.05 | — | $6.85 M | — | -1607.2% | -3.82% | $6.47 / $1.89 | $0.83 |
| 3. | PROCEPT BioRobotics Corporation | $25.73 | — | $1.45 B | — | -23.48% | -24.89% | $66.85 / $19.35 | $6.5 |
| 4. | Inspira Technologies Oxy B.H.N. Ltd. | $0.59 | — | $21.71 M | — | -541.24% | -3.98% | $1.65 / $0.34 | $0.07 |
| 5. | UFP Technologies, Inc. | $201.08 | 22.53 | $1.54 B | — | 16.02% | 17.82% | $274.93 / $182.87 | $54.95 |
| 6. | Intelligent Bio Solutions Inc. | $2.93 | — | $5.86 M | — | -359.62% | -1.5% | $24.9 / $2.42 | $8.96 |
| 7. | Profusa, Inc. | $0.66 | — | $3.05 M | — | 8.32% | 8.05% | $957 / $0.41 | $-61.03 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 434.93 M | 402.06 M | 415.61 M | 382.65 M | 442.65 M | — |
| Operating Profit | 23.04 M | 11.76 M | -1.31 M | -15.5 M | 35.63 M | — |
| Net Profit | -1.7 M | -5.4 M | -484.07 M | -25.29 M | 19.43 M | — |
| EPS in Rs | -0.02 | -0.07 | -6.21 | -0.32 | 0.25 | -0.14 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 1.64 B | 1.61 B | 1.54 B | 1.56 B |
| Operating Profit | 18 M | 28.41 M | 111.53 M | 238.92 M |
| Net Profit | -516.47 M | -6.94 M | 67.74 M | 180.55 M |
| EPS in Rs | -6.63 | -0.09 | 0.87 | 2.32 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 3.6 B | 4.04 B | 3.78 B | 3.89 B |
| Total Liabilities | 2.56 B | 2.49 B | 2.19 B | 2.09 B |
| Equity | 1.04 B | 1.55 B | 1.59 B | 1.8 B |
| Current Assets | 1.16 B | 1.08 B | 1.06 B | 1.16 B |
| Current Liabilities | 455.98 M | 922.13 M | 306.98 M | 320.91 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 50.38 M | 129.38 M | 139.96 M | 264.47 M |
| Investing CF | -108.06 M | -390.81 M | -94.18 M | -58.58 M |
| Financing CF | 28.34 M | 237.86 M | -229.93 M | -251.95 M |
| Free CF | -45.25 M | 15.01 M | 73.09 M | 217.38 M |
| Capex | -95.64 M | -114.37 M | -66.86 M | -47.09 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 4.47% | -1.03% | — | — |
| Earnings Growth % | -110.25% | -62.48% | — | — |
| Profit Margin % | -0.43% | 4.39% | 11.59% | — |
| Operating Margin % | 1.76% | 7.23% | 15.34% | — |
| Gross Margin % | 54.77% | 57.39% | 62.29% | — |
| EBITDA Margin % | 12% | 16.6% | 24.51% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.